Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Is this historic!
View:
Post by Tulsa123 on Jun 06, 2024 12:01pm

Is this historic!

Are they on a path of a great discovery. Why is this information not exploding on news and stocks.I am pleasantly joyful, hopeful this is true.
Comment by Oilminerdeluxe on Jun 06, 2024 12:24pm
We've been asking ourselves that for the last 7-8 years or so...:-)
Comment by Tulsa123 on Jun 06, 2024 12:37pm
Ventures news slow , Canadian stock I don't know this should be alarming to All.Who is getting this information.?
Comment by Alamir1111 on Jun 06, 2024 12:45pm
Good entry point 
Comment by Alamir1111 on Jun 06, 2024 12:47pm
Early bird gets the  
Comment by plantrader on Jun 06, 2024 2:17pm
Maybe potentially bigger buyers, despite this exchange being rightfully shunned by most, realize that another PP is coming very soon and don't want to buy prior to it. Because they know any new tangible developments from this latest amazing news are likely quite a ways off?
Comment by menoalittle on Jun 06, 2024 3:01pm
Perhaps, but these are the exact folk I was  saying that with this week's news ought to have alarm bells going off in their heads, and wake up to the fact the selling of any shares with the expectation of replacing them in a pp with cheaper priced shares is the wrong play here.  This is plainly the time to  buy... and then buy higher... and then buy higher again.  THAT is ...more  
Comment by plantrader on Jun 06, 2024 3:06pm
I get it, but you sound so certain. Why? Is it possible that this exchange itself wards off any impacful investors? No offense to any of us here, but you know what I mean. That seems to be the history so far. No matter what the NRs say, no matter the experts in the field being quoted, the stock does little to nothing. It's starting to seem like official FDA milestones are the only thing that ...more  
Comment by menoalittle on Jun 06, 2024 4:23pm
>> I get it, but you sound so certain. Why? Let's just say, more than a few years trading experience (call it a pretty good hunch, if you want), and... well... menoalittle... lol.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250